• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Search for pathological diagnosis using circulation tumor cells in gastrointestinal cancer

Research Project

Project/Area Number 16K19381
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Gastroenterology
Research InstitutionNational Cancer Center Japan

Principal Investigator

Shoji Hirokazu  国立研究開発法人国立がん研究センター, 中央病院, 医員 (50765568)

Research Collaborator Honda Kazufumi  
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2018: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2017: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2016: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywordscirculating tumor cell / circulating tumor DNA / gastrointestinal cancer / liquid biopsy / 末梢循環腫瘍細胞 / 消化管がん / リキッドバイオプシー / 次世代シークエンス / 1細胞オミクス解析 / バイオマーカー / オミクス解析
Outline of Final Research Achievements

We established a method employing a label-free inertial microfluidics approach (LFIMA) with next-generation sequencing (NGS) for the analysis of genomic alterations in circulating tumor cells (CTCs) isolated from patients with gastrointestinal (GI) cancer. CTCs could be isolated from a total of 20 peripheral blood cases, including advanced gastrointestinal cancer.In addition, we carried out blood-based molecular profiling to identify actionable drug targets, monitor drug resistance, and track tumor dynamics using CTCs and ctDNA from patients with metastatic colorectal cancer (CRC).

Academic Significance and Societal Importance of the Research Achievements

CTCs から消化管がんの「がんの個性診断法」を実現できれば、最少侵襲で時々刻々変化するがん細胞に対して「適時・最適医療」を提示できるようになると考え、本研究を進めてきた。そして分離したCTCsからの遺伝子変異解析、メタボローム解析が可能でることを証明した。今後は本技術を用いて臨床試験への応用、そしてCTCsの細胞培養が実現できれば、プロテオーム解析や薬剤感受性試験につながり、個々の患者に適した薬剤の提供につながる可能性があり、国内外へのインパクトが非常に高いと考える。また、LFIMAによる診断技術の創出は他の医工学分野の発展にもつながり、新しい医工学の学術領域を創出できる可能性がある。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (42 results)

All 2019 2018 2017 2016

All Journal Article (27 results) (of which Int'l Joint Research: 5 results,  Peer Reviewed: 25 results,  Open Access: 14 results,  Acknowledgement Compliant: 2 results) Presentation (15 results) (of which Int'l Joint Research: 11 results)

  • [Journal Article] Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report.2019

    • Author(s)
      Watanabe S, Honma Y, Murakami N, Igaki H, Mori T, Hirano H, Okita N, Shoji H, Iwasa S, Takashima A, Kato K, Kobayashi K, Matsumoto F, Yoshimoto S, Itami J, Boku N.
    • Journal Title

      World J Clin Cases.

      Volume: 7(6) Issue: 6 Pages: 765-772

    • DOI

      10.12998/wjcc.v7.i6.765

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Serum level of octanoic acid predicts the efficacy of chemotherapy for colorectal cancer.2019

    • Author(s)
      Iemoto T, Nishiumi S, Kobayashi T, Fujigaki S, Hamaguchi T, Kato K, Shoji H, Matsumura Y, Honda K, Yoshida M.
    • Journal Title

      Oncol Lett.

      Volume: 17(1) Pages: 831-842

    • DOI

      10.3892/ol.2018.9731

    • NAID

      120006554635

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer.2019

    • Author(s)
      Yamaguchi T, Iwasa S, Shoji H, Honma Y, Takashima A, Kato K, Hamaguchi T, Higuchi K, Boku N.
    • Journal Title

      Gastric Cancer.

      Volume: 印刷中 Issue: 4 Pages: 778-784

    • DOI

      10.1007/s10120-018-00917-5

    • NAID

      40021925970

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.2019

    • Author(s)
      Nishiumi S, Fujigaki S, Kobayashi T, Kojima T, Ito Y, Daiko H, Kato K, Shoji H, Kodama Y, Honda K, Yoshida M.
    • Journal Title

      Anticancer Res.

      Volume: 39(1) Issue: 1 Pages: 519-526

    • DOI

      10.21873/anticanres.13143

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Live single cell mass spectrometry reveals cancer‐specific metabolic profiles of circulating tumor cells2019

    • Author(s)
      Abouleila Yasmine、Onidani Kaoru、Ali Ahmed、Shoji Hirokazu、Kawai Takayuki、Lim Chwee Teck、Kumar Vipin、Okaya Shinobu、Kato Ken、Hiyama Eiso、Yanagida Toshio、Masujima Tsutomu、Shimizu Yoshihiro、Honda Kazufumi
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 2 Pages: 697-706

    • DOI

      10.1111/cas.13915

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.2019

    • Author(s)
      Honda K, Katzke VA, Hüsing A, Okaya S, Shoji H, et al.
    • Journal Title

      Int J Cancer.

      Volume: 144(8) Issue: 8 Pages: 1877-1887

    • DOI

      10.1002/ijc.31900

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.2018

    • Author(s)
      Ida H, Honma Y, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Kato K, Fukuda T, Boku N.
    • Journal Title

      Invest New Drugs.

      Volume: 印刷中 Issue: 3 Pages: 573-578

    • DOI

      10.1007/s10637-018-0669-7

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.2018

    • Author(s)
      Sekine K, Hamaguchi T, Shoji H, Takashima A, Honma Y, Iwasa S, Kato K, Takahashi K, Kato T, Kanemitsu Y, Boku N.
    • Journal Title

      Oncology.

      Volume: 95(4) Issue: 4 Pages: 220-228

    • DOI

      10.1159/000489665

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer2018

    • Author(s)
      Shoji Hirokazu、Miura Nami、Ueno Hideki、Honda Kazufumi
    • Journal Title

      Pancreatology

      Volume: 18 Issue: 6 Pages: 624-629

    • DOI

      10.1016/j.pan.2018.06.003

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma.2018

    • Author(s)
      Hiramoto S, Kato K, Shoji H, Okita N, Takashima A, Honma Y, Iwasa S, Hamaguchi T, Yamada Y, Shimada Y, Boku N.
    • Journal Title

      Int J Clin Oncol.

      Volume: 印刷中 Issue: 3 Pages: 466-472

    • DOI

      10.1007/s10147-018-1239-x

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.2018

    • Author(s)
      Sudo K, Kato K, Kuwabara H, Sasaki Y, Takahashi N, Shoji H, Iwasa S, Honma Y, Okita NT, Takashima A, Hamaguchi T, Yamada Y, Ito Y, Itami J, Fukuda T, Tobinai K, Boku N.
    • Journal Title

      Oncology.

      Volume: 94(1) Issue: 1 Pages: 47-54

    • DOI

      10.1159/000480515

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy2017

    • Author(s)
      Shoji Hirokazu、Tada Kohei、Kitano Shigehisa、Nishimura Takashi、Shimada Yasuhiro、Nagashima Kengo、Aoki Kazunori、Hiraoka Nobuyoshi、Honma Yoshitaka、Iwasa Satoru、Takashima Atsuo、Kato Ken、Boku Narikazu、Honda Kazufumi、Yamada Tesshi、Heike Yuji、Hamaguchi Tetsuya
    • Journal Title

      Oncotarget

      Volume: 8 Issue: 56 Pages: 95083-95094

    • DOI

      10.18632/oncotarget.18297

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.2017

    • Author(s)
      Honma Y, Hokamura N, Nagashima K, Sudo K, Shoji H, Iwasa S, Takashima A, Kato K, Hamaguchi T, Boku N, Umezawa R, Ito Y, Itami J, Koyanagi K, Igaki H, Tachimori Y.
    • Journal Title

      Anticancer Res.

      Volume: 37(7) Pages: 3741-3749

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.2017

    • Author(s)
      Kakuya T, Mori T, Yoshimoto S, Watabe Y, Miura N, Shoji H, Onidani K, Shibahara T, Honda K.
    • Journal Title

      Int J Oral Maxillofac Surg.

      Volume: 46(8) Issue: 8 Pages: 968-976

    • DOI

      10.1016/j.ijom.2017.03.001

    • Related Report
      2017 Research-status Report 2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy.2017

    • Author(s)
      Shoji H, Tada k, Kitano S, Nishimura T, Shimada Y, Nagashima K, Aoki K, Hiraoka N, Honma Y, Iwasa S, Takashima A, Kato K, Boku N, Honda K, Yamada T, Heike Y, and Hamaguchi T.
    • Journal Title

      Oncotarget.

      Volume: In press

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Circulating tumor cellの同定と、その臨床応用2017

    • Author(s)
      庄司 広和、鬼谷 薫、吉本 世一、本田 一文、加藤 健
    • Journal Title

      腫瘍内科

      Volume: 19(4) Pages: 422-427

    • Related Report
      2016 Research-status Report
  • [Journal Article] A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab.2016

    • Author(s)
      Takahashi N, Iwasa S, Fukahori M, Sudo K, Sasaki Y, Shoji H, Honma Y, Okita NT, Takashima A, Hamaguchi T, Boku N, Shimada Y, Honda K, Yamada T, and Yamada Y.
    • Journal Title

      Cancer Chemother Pharmacol.

      Volume: Sep;78(3) Issue: 3 Pages: 567-75

    • DOI

      10.1007/s00280-016-3111-x

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer.2016

    • Author(s)
      Yamaguchi T, Iwasa S, Nagashima K, Ikezawa N, Hamaguchi T, Shoji H, Honma Y, Takashima A, Okita N, Kato K, Yamada Y, and Shimada Y.
    • Journal Title

      Anticancer Res.

      Volume: Jul;36(7) Pages: 3531-6

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Journal Article] Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.2016

    • Author(s)
      Takahashi N, Iwasa S, Sasaki Y, Shoji H, Honma Y, Takashima A, Okita NT, Kato K, Hamaguchi T, and Yamada Y.
    • Journal Title

      J Cancer Res Clin Oncol.

      Volume: Aug;142(8) Issue: 8 Pages: 1727-38

    • DOI

      10.1007/s00432-016-2184-6

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Journal Article] Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients.2016

    • Author(s)
      Tada K, Kitano S, Shoji H, Nishimura T, Shimada Y, Nagashima K, Aoki K, Hiraoka N, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Yamada Y, Katayama N, Boku N, Heike Y, Hamaguchi T.
    • Journal Title

      Cancer immunology research

      Volume: 4(7) Issue: 7 Pages: 592-599

    • DOI

      10.1158/2326-6066.cir-15-0298

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Efficacy of adjuvant chemotherapy for non-small cell lung cancer assesed by metastatic potential assocaited with ACTN42016

    • Author(s)
      Miura N, Kamita M, Kakuya T, Fujiwara Y, Tsuta K, Shiraishi H, Takeshita F, Ochiya T, Hirokazu Shoji, Huang W, Ohe Y, Yamada T, Honda K
    • Journal Title

      Oncotarget

      Volume: Apr 21 Issue: 22 Pages: 1-14

    • DOI

      10.18632/oncotarget.8890

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies.2016

    • Author(s)
      Takahashi N, Iwasa S, Taniguchi H, Sasaki Y, Shoji H, Honma Y, Takashima A, Okita N, Kato K, Hamaguchi T, Shimada Y, and Yamada Y.
    • Journal Title

      Br J Cancer.

      Volume: Apr 26;114(9) Issue: 9 Pages: 1003-11

    • DOI

      10.1038/bjc.2016.74

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.2016

    • Author(s)
      Sasaki Y, Hamaguchi T, Yamada Y, Takahashi N, Shoji H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Nagai Y, Taniguchi H, Boku N, Ushijima T, and Shimada Y.
    • Journal Title

      Asian Pac J Cancer Prev.

      Volume: 17(2) Pages: 539-43

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.2016

    • Author(s)
      Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K.
    • Journal Title

      Cancer Sci.

      Volume: 印刷中 Issue: 5 Pages: 590-600

    • DOI

      10.1111/cas.12919

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer.2016

    • Author(s)
      Takahashi N, Furuta K, Taniguchi H, Sasaki Y, Shoji H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Hamaguchi T, Shimada Y, and Yamada Y.
    • Journal Title

      Oncotarget.

      Volume: Jan 26;7(4) Issue: 4 Pages: 4925-38

    • DOI

      10.18632/oncotarget.6753

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.2016

    • Author(s)
      Shoji H, Morizane C, Sakamoto Y, Kondo S, Ueno H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S, Ikeda M, Okusaka T.
    • Journal Title

      Japanese journal of clinical oncology

      Volume: 46 Pages: 132-137

    • DOI

      10.1093/jjco/hyv179

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] 血液apolipoprotein-A2 isoforms による早期膵がんの診断2016

    • Author(s)
      鬼谷 薫、庄司 広和、本田 一文
    • Journal Title

      がん分子標的治療

      Volume: 14(4) Pages: 108-113

    • Related Report
      2016 Research-status Report
  • [Presentation] The hyperprogressive disease during nivolumab treatment or irinotecan treatment in patients with advanced gastric cancer.2019

    • Author(s)
      Aoki M, Shoji H, Imazeki H, Miyamoto T, Hirano H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Boku N.
    • Organizer
      2019 ASCO Gastrointestinal Cancers Symposium
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Survival impact of the response at 12 weeks in patients with advanced gastric cancer received firstline chemotherapy.2019

    • Author(s)
      Arakaki M, Aoki M, Imazeki H, Shoji H, Honma Y, Iwasa S, Okita N,Takashima A, Kato K, Boku N.
    • Organizer
      2019 ASCO Gastrointestinal Cancers Symposium
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Phase 1/2 study of ramucirumab plus nivolumab in patients in second line treatment for advanced gastric adenocarcinoma (NivoRam study).2019

    • Author(s)
      Hara H, Shoji H, Takahari D, Esaki T, Machida N, Nagashima K, Aoki K, Honda K, Miyamoto T, Boku N, Kato K.
    • Organizer
      2019 ASCO Gastrointestinal Cancers Symposium
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Preliminary result of phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma (NivoRam study)2018

    • Author(s)
      Takahari D, Shoji H, Hara H, Esaki T, Machida N, Nagashima K, Aoki K, Honda K, Miyamoto T, Boku N, Kato K.
    • Organizer
      2018 ASCO annual meeting
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 次世代シーケンサーによる血中循環腫瘍細胞(CTCs)および血中腫瘍循環DNA(ctDNA)のリアルタイムモニタリング2018

    • Author(s)
      鬼谷薫、庄司広和、吉本世一、三浦奈美、柴原孝彦、加藤健、本田一文
    • Organizer
      日本分子腫瘍マーカー研究会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Expression of B7-H3 (CD276) in surgically resected esophageal squamous cell carcinoma2018

    • Author(s)
      Maruki Y, Takashima A, Miyamoto T, Hirano H, Shoji H, Honma Y, Iwasa S, Okita N, Kato K, Sekine S, Koyanagi K, Daiko H, Kitano S, Aoki K, Boku N
    • Organizer
      American Society of Clinical Oncology 2018 Gastrointesinal Cancer Symposium
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma.2017

    • Author(s)
      Shoji H, Miyamoto H, Takahari D, Hara H, Machida N, Esaki T, Nagashima K, Aoki K, Honda K, Nagata Y, Miyamoto T, Boku N, Kato K.
    • Organizer
      European Society for Medical Oncology 2017 Congress
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] Next-generation sequencing of circulating tumor cells isolated from peripheral blood of patients with head and neck or gastrointestinal cancer.2017

    • Author(s)
      Onidani K, Yoshimoto S, Miura N, Shoji H, Kato K, Shibahara T, Honda K.
    • Organizer
      European Society for Medical Oncology 2017 Congress Asia 2017
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] Possibility of a novel molecular therapeutic target for tongue cancer.2017

    • Author(s)
      Onidani K, Kakuya T, Watabe Y, Miura N, Shoji H, Shibahara T, Honda K.
    • Organizer
      Human Proteome Organisation World Congress 2017
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] Evaluation of the safety and efficacy of combined the KM-CART and chemotherapy for gastrointestinal cancers with massive ascites.2017

    • Author(s)
      Y. Nagata, K. Kato, H. Matsushita, T. Yamaguchi, T. Miyamoto, H. Shoji, S. Iwasa, Y. Honma, A. Takashima, T. Hamaguchi, M. Saruta, N. Boku
    • Organizer
      European Society for Medical Oncology 2017 Congress Asia 2017
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma.2017

    • Author(s)
      Shoji H, Miyamoto H, Takahari D, Hara H, Machida N, Esaki T, Nagashima K, Aoki K, Honda K, Nagata Y, Miyamoto T, Boku N, Kato K.
    • Organizer
      日本臨床腫瘍学会学術集会
    • Related Report
      2017 Research-status Report
  • [Presentation] Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.2017

    • Author(s)
      Onidani K, Kakuya T, Miura N, Shoji H, Shibahara T, Honda K.
    • Organizer
      日本癌学会学術総会
    • Related Report
      2017 Research-status Report
  • [Presentation] 次世代シーケンサーによる血中循環腫瘍細胞(CTCs)の遺伝子変異プロファイリング2017

    • Author(s)
      鬼谷 薫、吉本世一、三浦奈美、庄司広和、加藤 健、柴原孝彦、本田一文
    • Organizer
      日本分子腫瘍マーカー研究会
    • Related Report
      2017 Research-status Report
  • [Presentation] Next-generation sequencing of circulating tumor cells isolated from peripheral blood of patients with head and neck or gastrointestinal cancer2016

    • Author(s)
      H.Shoji, K.Kato, S.Yoshimoto, F.Kakizaki, K.Furuta, K.Onidani, N.Miura, K.Honda.
    • Organizer
      ESMO 2016 Congress
    • Place of Presentation
      Copenhagen, Denmark
    • Year and Date
      2016-10-07
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research
  • [Presentation] Assessment of efficacy of adjuvant chemotherapy for non-small cell lung cancer with metastatic ability involving ACTN42016

    • Author(s)
      K.Honda, N.Miura, H.Shiraishi, K.Onidani, H.Shoji, T.Yamada, Y.Fujiwara, Y.Ohe
    • Organizer
      ESMO 2016 Congress
    • Place of Presentation
      Copenhagen, Denmark
    • Year and Date
      2016-10-07
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi